A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema

Clinical trial NCT06305416 · RECRUITING

Trial details

NCT number: NCT06305416
Sponsor: Incepta Pharmaceuticals Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema Diabetic Retinopathy Macular Edema Macular Degeneration Retinal Disease Retinal Degeneration

Start date: 2024-03-30
Primary completion: 2025-10-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.